New contraceptive
March 10, 2014
A NEW contraceptive has
been developed which could
protect women from unwanted
pregnancies and HIV at the same
time.
The as yet unnamed ring, inserted
into the vagina, lasts for up to 90
days and delivers the anit-HIV drug
tenofovir and the contraceptive
levonorgestrel at differing doses.
The ring could be of particular
help to women in low-income
countries, should a partner refuse
to wear a condom, and had been
tested on sheep, with the team
awaiting approval for a trial in the
US, the New Scientist reported.
The ring costs about US$10, the
publication said, and the team
behind the device hoped to have it
available in other countries within
the next five years.
Published in PLOS One, the study
of the ring said the device could
“easily” be configured to deliver
other drugs and a wide range of
doses or combinations for other
women’s health challenges.
To read the study, CLICK HERE.
The above article was sent to subscribers in Pharmacy Daily's issue from 10 Mar 14To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 10 Mar 14